Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bird Selected as Preferred Proponent for a Major Hospital Project in Ontario
-
NewtekOne, Inc. Declares Dividend on Series B Preferred Shares
-
MEDIA ADVISORY: Rally to Save the Post Office
-
Roadpost Inc. Responds to Beam Communications Holdings Ltd.’s ASX Announcements Regarding ZOLEO Inc.
-
Viomi Celebrates 7th Nasdaq Anniversary with New Brand Campaign and U.S. Launch of AI Alkaline Mineral Water Purifier, MASTER M1
-
Rogers Communications 3Q25 Investment Community Teleconference October 23, 2025 at 8:00 a.m. ET
-
RGC Resources, Inc. Declares Quarterly Dividend
-
Eloro Resources Announces Annual and Special Meeting Voting Results
-
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
-
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
-
Cboe Validus S&P 500 Dynamic PutWrite Index ETF (PUTD) to Close
-
Magnera Announces Strategic Exit from Argentina as Part of Project CORE Transformation
-
Creative Global Technology Holdings Limited Announces Fiscal 2025 First Half Financial Results
-
Indiaspora Announces the Philanthropy Summit in partnership with the India Philanthropy Alliance
-
SiriusPoint Announces Sale of ArmadaCare MGA for $250m with Long Term Capacity Deal Until 2030
-
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Concorde International Group Reports 11% Year-over-Year Revenue Growth to $6.0 million for H1 of 2025
-
IDT Corporation Reports Fourth Quarter and Fiscal Year 2025 Results
-
Rocket Lab and Synspective Strike Another 10-Launch Deal, Boosting Contracted Missions to 21 Electron Launches
-
AIQuant’s AI-Driven, High-Frequency Crypto Trading Platform Goes Live
-
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
-
MAIA Biotechnology Announces $2.25 Million Private Placement
-
Megan Holdings Limited Announces Closing of $5 Million Initial Public Offering
-
American Rebel Holdings, Inc. (NASDAQ: AREB) and TSR Nitro Celebrate the American Rebel Beer Dodge Hellcat Victory at NHRA Midwest Nationals—Matt Hagan Wins Big in St. Louis
-
Notice to General Meeting
-
Phoenix Energy Announces Closing of Preferred Share Initial Public Offering and Expected Date for Trading on NYSE American
-
Arbor Realty Trust Declares Preferred Stock Dividends
-
California Water Service Opens 2025 Firefighter Grant Program
-
Wabash Opens Midwest Parts and Services Center in Chicagoland
-
Nasdaq to Hold Third Quarter 2025 Investor Conference Call
-
ONEOK to Participate in Investor Conference
-
FAIRCHILD TO ACQUIRE 100% OF ADVANCED STAGE GOLDEN ARROW PROJECT FURTHER EXPANDING ITS FOOTPRINT ON THE WALKER LANE SHEAR ZONE REGION OF NEVADA
-
Lesaka’s Final FY2025 Results: Delivers on FY2025 Profitability Guidance, Reaffirms FY2026 Profitability & Net Revenue Outlook, and Sets FY2026 Profitability per Share Guidance, reflecting more
-
CPS Technologies Awarded Phase I SBIR Contract from the U.S. Department of Energy's Office of Nuclear Energy
-
Lesaka’s Final FY2025 Results: Delivers on FY2025 Profitability Guidance, Reaffirms FY2026 Profitability & Net Revenue Outlook, and Sets FY2026 Profitability per Share Guidance, reflecting more than
-
Sunrise Secures U.S. Patent for Advanced Lithium-Ion Battery Anode Material Preparation Method, Strengthening Its Leading Position in the United States
-
Experior Financial Group Announces Strategic Alliance with Associate Owners Group Inc.
-
Experior Financial Group Announces Strategic Alliance with Associate Owners Group Inc.
-
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
-
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
-
ImmuCell Announces Selection of its Next President and CEO
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
-
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Aimfinity Investment Corp. I Announces New Monthly Extension for Business Combination
-
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
-
Alameda Health System is recognized as one of Newsweek’s America’s Best Nursing Homes 2026
-
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Can
-
Progress Software Announces Third Quarter 2025 Financial Results
